KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

Overview of attention for article published in Kidney International, December 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source
twitter: 128 X users

facebook: 3 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 116 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.

Clinical guideline published by Kidney Disease: Improving Global Outcomes (KDIGO) on 12 Dec 2023

Kidney Disease: Improving Global Outcomes (KDIGO) is a global nonprofit organization dedicated to enhancing kidney disease care through evidence-based clinical practice guidelines. Their mission focuses on translating scientific evidence into practical recommendations for clinicians and patients worldwide.

Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

Clinical guideline published by Kidney Disease: Improving Global Outcomes (KDIGO) on 01 Dec 2022

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.